OVERVIEW

Prostamax 20mg (Bioregulator) is a peptide-based compound classified within the group of cytomedine bioregulators. It is derived from prostate tissue extracts and is designed to support the functional health of prostate cells. Bioregulator peptides are short chains of amino acids believed to help normalize cellular activity by influencing gene expression and protein synthesis within specific organs. Prostamax has been explored in research focused on maintaining prostate tissue structure and supporting age-related changes in male reproductive health. Its proposed mechanism centers on promoting balanced cellular renewal and helping preserve normal organ function.

At a 20mg dosage, Prostamax is typically available in capsule form for supplemental or research use in certain regions. It has been studied for its potential role in supporting urinary comfort, prostate tissue resilience, and overall male wellness, particularly in aging populations. Some research suggests that organ-specific bioregulators may help maintain cellular stability and reduce functional decline over time, although large-scale international clinical trials remain limited. Prostamax is not widely approved as a prescription medication by major regulatory authorities, and its use is generally considered within specialized frameworks. As with any compound influencing reproductive or hormonal systems, consultation with a qualified healthcare professional is recommended before considering use.